業績|論文・出版物|目次|
2021
Monolayer platform using human biopsy-derived duodenal organoids for pharmaceutical research
Yamashita T., Inui T., Yokota J., Kawakami K., Morinaga G., Takatani M., Hirayama D., Nomoto R., Ito K., Cui Y., Ruez S., Harada K., Kishimoto W., Nakase H., Mizuguchi H.
Mol. Ther. Methods Clin. Dev., 22, 263-278 (2021)
(外部サイトへリンク)
Transduction properties of an adenovirus vector containing sequences complementary to a liver-specific microRNA, miR-122a, in the 3'-untranslated region of the E4 gene in human hepatocytes from chimeric mice with humanized liver.
Sakurai F., Tsukamoto T., Ono R., Nishimae F., Shiota A., Iizuka S., Shimizu K., Sakai E., Ishida Y., Tateno C., Chayama K., Mizuguchi H.
Biol. Pharm. Bull., 44, 1506-1513 (2021)
(外部サイトへリンク)
Generation of Tetrafluoroethylene-Propylene Elastomer-Based Microfluidic Devices for Drug Toxicity and Metabolism Studies.
Sano E., Deguchi S., Matsuoka N., Tsuda M., Wang M., Kosugi K., Mori C., Yagi K., Wada A., Yamasaki S., Kawai T., Yodogawa M, Mizuguchi H., Nakazawa N., Yamashita F., Torisawa Y.S., Takayama K.
ACS omega, 6, 24859-24865 (2021)
(外部サイトへリンク)
Usability of Polydimethylsiloxane-Based Microfluidic Devices in Pharmaceutical Research Using Human Hepatocytes.
Deguchi S., Tsuda M., Kosugi K., Sakamoto A., Mimura N., Negoro R., Sano E., Nobe T., Maeda K., Kusuhara H., Mizuguchi H., Yamashita F., Torisawa Y.S., Takayama K.
ACS Biomater. Sci. Eng., 7, 3648-3657 (2021)
(外部サイトへリンク)
A selective cytotoxic adenovirus vector for concentration of pluripotent stem cells in human pluripotent stem cell-derived neural progenitor cells.
Hirai T., Kono K., Sawada R., Kuroda T., Yasuda S., Matsuyama S., Matsuyama A., Koizumi N., Utoguchi N., Mizuguchi H., Sato Y.
Sci. Rep., 11, 11407 (2021)
(外部サイトへリンク)
Vinblastine treatment decreases the undifferentiated cell contamination of human iPSC-derived intestinal epithelial-like cells
Ichikawa M.#, Negoro R.#, Kawai K., Yamashita T., Takayama K., Mizuguchi H. #These authors equally contributed to this work.
Mol. Ther. Methods Clin. Dev., 20, 463-472 (2021)
(外部サイトへリンク)
In Vitro Model for a Drug Assessment of Cytochrome P450 Family 3 Subfamily A Member 4 Substrates Using Human Induced Pluripotent Stem Cells and Genome Editing Technology.
Deguchi S., Shintani T., Harada K., Okamoto T., Takemura A., Hirata K., Ito K., Takayama K., Mizuguchi H.
Hepatol.?Commun., 5, 1385-1399 (2021)